This opportunity is no longer accepting applications.
grant RFA-AI-24-064

Strategies for Eliminating HIV Proteins (R21 Clinical Trial Not Allowed)

This grant opportunity aims to fund projects that develop molecules targeting HIV proteins or RNA for degradation or that disrupt the translation of HIV RNA into protein. This innovative approach could potentially eliminate HIV proteins that are challenging to target with conventional drug discovery methods.

This purpose of this notice of funding opportunity (NOFO) is to support the development of molecules that target HIV proteins or RNA for degradation or that interfere with the translation of HIV RNA into protein. This approach has the potential of eliminating HIV proteins that have been difficul…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Allergy and Infectious Diseases

Awards & funding

Award Ceiling: $200,000
Award Amount: $200,000

Dates

Opportunity Released: August 29, 2024
Open for Submission: August 29, 2024
Submission Deadline: December 4, 2024
Application Window Closes: December 4, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.